JP2019528046A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019528046A5 JP2019528046A5 JP2019501641A JP2019501641A JP2019528046A5 JP 2019528046 A5 JP2019528046 A5 JP 2019528046A5 JP 2019501641 A JP2019501641 A JP 2019501641A JP 2019501641 A JP2019501641 A JP 2019501641A JP 2019528046 A5 JP2019528046 A5 JP 2019528046A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- antigen
- binding fragment
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1612337.4 | 2016-07-15 | ||
| GBGB1612337.4A GB201612337D0 (en) | 2016-07-15 | 2016-07-15 | Ant-il-22r antibodies |
| PCT/EP2017/067923 WO2018011420A1 (en) | 2016-07-15 | 2017-07-14 | Anti-il-22r antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019528046A JP2019528046A (ja) | 2019-10-10 |
| JP2019528046A5 true JP2019528046A5 (enExample) | 2020-08-06 |
| JP7163275B2 JP7163275B2 (ja) | 2022-10-31 |
Family
ID=56890507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019501641A Active JP7163275B2 (ja) | 2016-07-15 | 2017-07-14 | 抗－ｉｌ－２２ｒ抗体 |
Country Status (28)
| Country | Link |
|---|---|
| US (4) | US10696741B2 (enExample) |
| EP (2) | EP3484921B1 (enExample) |
| JP (1) | JP7163275B2 (enExample) |
| KR (2) | KR102571012B1 (enExample) |
| CN (1) | CN109641966B (enExample) |
| AU (1) | AU2017296094B2 (enExample) |
| BR (1) | BR112019000788A2 (enExample) |
| CA (1) | CA3024370A1 (enExample) |
| CY (1) | CY1125041T1 (enExample) |
| DK (1) | DK3484921T3 (enExample) |
| ES (1) | ES2903412T3 (enExample) |
| GB (1) | GB201612337D0 (enExample) |
| HR (1) | HRP20220197T1 (enExample) |
| HU (1) | HUE057615T2 (enExample) |
| IL (1) | IL264262B2 (enExample) |
| LT (1) | LT3484921T (enExample) |
| MX (1) | MX2019000539A (enExample) |
| MY (1) | MY197821A (enExample) |
| PL (1) | PL3484921T3 (enExample) |
| PT (1) | PT3484921T (enExample) |
| RS (1) | RS62884B1 (enExample) |
| RU (1) | RU2758721C2 (enExample) |
| SA (1) | SA519400856B1 (enExample) |
| SG (1) | SG11201900128XA (enExample) |
| SI (1) | SI3484921T1 (enExample) |
| UA (1) | UA125585C2 (enExample) |
| WO (1) | WO2018011420A1 (enExample) |
| ZA (1) | ZA201807816B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201612337D0 (en) | 2016-07-15 | 2016-08-31 | Argen-X N V | Ant-il-22r antibodies |
| MX2020013243A (es) | 2018-06-05 | 2021-05-12 | Bioatla Inc | Anticuerpos anti-il-22, fragmentos de anticuerpo, sus inmunoconjugados y usos de los mismos. |
| CN110302363B (zh) * | 2019-07-04 | 2020-10-09 | 北京大学第三医院（北京大学第三临床医学院） | Il-22作为制备治疗pcos药物的应用及药物制剂 |
| WO2021241730A1 (ja) * | 2020-05-29 | 2021-12-02 | 第一三共株式会社 | 炎症性腸疾患に対する治療用抗体 |
| US20250339371A1 (en) | 2022-06-03 | 2025-11-06 | Leo Pharma A/S | Liquid formulation of il-22r antibody |
| EP4704974A1 (en) | 2023-03-08 | 2026-03-11 | LEO Pharma A/S | Il-22r antibody for use in treating atopic dermatitis |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| DE602004028347D1 (de) | 2003-03-24 | 2010-09-09 | Zymogenetics Inc | Anti-il-22ra antikörper und bindungspartner und verwendungsmethoden bei entzündung |
| EA015706B1 (ru) * | 2004-10-22 | 2011-10-31 | Займоджинетикс, Инк. | Моноклональное антитело или его фрагмент, связывающиеся с полипептидом il-22ra, гуманизированное антитело, полученное из указанного антитела, гибридомы, продуцирующие антитело, и применение указанного антитела |
| JP2009518314A (ja) * | 2005-12-02 | 2009-05-07 | ジェネンテック・インコーポレーテッド | Ｉｌ−２２に結合する抗体およびｉｌ−２２ｒに結合する抗体を含む、サイトカインシグナリングに関連する疾患および障害の処置のための組成物および方法 |
| GB2461546B (en) | 2008-07-02 | 2010-07-07 | Argen X Bv | Antigen binding polypeptides |
| MX2012005791A (es) * | 2009-11-19 | 2012-07-03 | Merck Serono Sa | Anticuerpos humanizados contra el receptor alfa de la interleucina 22 humana. |
| GB2476681B (en) | 2010-01-04 | 2012-04-04 | Argen X Bv | Humanized camelid VH, VK and VL immunoglobulin domains |
| GB2504139B (en) * | 2012-07-20 | 2014-12-31 | Argen X Bv | Antibodies to highly conserved targets produced by the immunisation of Camelidae species |
| WO2013087914A1 (en) * | 2011-12-16 | 2013-06-20 | Synthon Biopharmaceuticals B.V. | EXPRESSION OF SECRETORY IgA ANTIBODIES IN DUCKWEED |
| AU2013310924B2 (en) | 2012-08-31 | 2017-08-03 | Argenx Bvba | Method for producing antibody molecules having inter-species, intra-target cross-reactivity |
| WO2014133728A2 (en) * | 2013-03-01 | 2014-09-04 | Albert Einstein College Of Medicine Of Yeshiva University | Hhla2 as a novel inhibitor of human immune system and uses thereof |
| CN105601739B (zh) * | 2016-02-22 | 2019-01-18 | 王晨辉 | 一种人源化抗白介素22基因工程抗体及其应用 |
| GB201612337D0 (en) | 2016-07-15 | 2016-08-31 | Argen-X N V | Ant-il-22r antibodies |
-
2016
- 2016-07-15 GB GBGB1612337.4A patent/GB201612337D0/en not_active Ceased
-
2017
- 2017-07-14 AU AU2017296094A patent/AU2017296094B2/en active Active
- 2017-07-14 RS RS20220105A patent/RS62884B1/sr unknown
- 2017-07-14 SI SI201731037T patent/SI3484921T1/sl unknown
- 2017-07-14 LT LTEPPCT/EP2017/067923T patent/LT3484921T/lt unknown
- 2017-07-14 PT PT177460110T patent/PT3484921T/pt unknown
- 2017-07-14 RU RU2019103991A patent/RU2758721C2/ru active
- 2017-07-14 EP EP17746011.0A patent/EP3484921B1/en active Active
- 2017-07-14 EP EP21208038.6A patent/EP4023674A3/en not_active Withdrawn
- 2017-07-14 IL IL264262A patent/IL264262B2/en unknown
- 2017-07-14 JP JP2019501641A patent/JP7163275B2/ja active Active
- 2017-07-14 PL PL17746011T patent/PL3484921T3/pl unknown
- 2017-07-14 CN CN201780053328.1A patent/CN109641966B/zh active Active
- 2017-07-14 HR HRP20220197TT patent/HRP20220197T1/hr unknown
- 2017-07-14 CA CA3024370A patent/CA3024370A1/en active Pending
- 2017-07-14 KR KR1020197001500A patent/KR102571012B1/ko active Active
- 2017-07-14 SG SG11201900128XA patent/SG11201900128XA/en unknown
- 2017-07-14 MY MYPI2018002752A patent/MY197821A/en unknown
- 2017-07-14 WO PCT/EP2017/067923 patent/WO2018011420A1/en not_active Ceased
- 2017-07-14 UA UAA201901458A patent/UA125585C2/uk unknown
- 2017-07-14 HU HUE17746011A patent/HUE057615T2/hu unknown
- 2017-07-14 ES ES17746011T patent/ES2903412T3/es active Active
- 2017-07-14 DK DK17746011.0T patent/DK3484921T3/da active
- 2017-07-14 KR KR1020237028376A patent/KR20230128137A/ko not_active Ceased
- 2017-07-14 MX MX2019000539A patent/MX2019000539A/es unknown
- 2017-07-14 BR BR112019000788-1A patent/BR112019000788A2/pt active Search and Examination
-
2018
- 2018-11-20 ZA ZA2018/07816A patent/ZA201807816B/en unknown
-
2019
- 2019-01-08 US US16/242,760 patent/US10696741B2/en active Active
- 2019-01-10 SA SA519400856A patent/SA519400856B1/ar unknown
- 2019-10-23 US US16/661,783 patent/US11447544B2/en active Active
- 2019-10-23 US US16/661,757 patent/US11261246B2/en active Active
-
2022
- 2022-02-04 CY CY20221100099T patent/CY1125041T1/el unknown
- 2022-08-11 US US17/819,161 patent/US20230088269A1/en not_active Abandoned